Multivessel coronary atherosclerotic disease in exclusive pharmacological treatment: case report and a critical literature review
Doença aterosclerótica coronária multiarterial em tratamento farmacológico exclusivo: relato de caso e revisão crítica da literatura
Palavras-chave:
Coronary artery disease, Multivessel, Atherosclerotic diseaseResumo
Three-vessel coronary atherosclerotic disease (CAD) presents a clinical challenge in managing heart cardiac patients, especially when they resist undergoing interventional therapies such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). This article presents a challeging case report of a patient with three-vessel CAD who refused invasive therapies and was managed solely through medical treatment. It also critically reviews the literature on the atual benefits and drawbacks of medical treatment versus interventional therapies in multivessel CAD. The recommendations from Cardiology Societies, as well as data from randomized controlled trials (RCTs), were critically analyzed, comparing outcomes such as mortality, morbidity, and quality of life, in order to assess the actual magnitude of benefit across different therapeutic modalities. In selected cases, the current optimized medical therapy (OMT) alone may be a viable alternative, particularly for patients who refuse invasive interventions.
Downloads
Referências
BODEN, W. E. et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine, v. 356, n. 15, p. 1503–1516, 12 abr. 2007.
CESAR, L. A. et al. Guideline for Stable Coronary Artery Disease. Arq. bras. cardiol, p. 1–59, 2014.
CHRISTIAAN VRINTS et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal, 30 ago. 2024.
FARKOUH, M. E. et al. Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine, v. 367, n. 25, p. 2375–2384, 20 dez. 2012.
FRYE, R. L. et al. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. New England Journal of Medicine, v. 360, n. 24, p. 2503–2515, 11 jun. 2009.
HOCHMAN, J. S. et al. Coronary Intervention for Persistent Occlusion after Myocardial Infarction. New England Journal of Medicine, v. 355, n. 23, p. 2395–2407, 7 dez. 2006.
HUEB, W. et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease. Journal of the American College of Cardiology, v. 43, n. 10, p. 1743–1751, maio 2004.
HUSSAIN, A. et al. Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, GBR 2. Trauma and Orthopaedics. Urology, v. 15, n. 11, 2023.
IQBAL, J. et al. Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting. Circulation, v. 131, n. 14, p. 1269–1277, 7 abr. 2015.
MARON, D. J. et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. New England Journal of Medicine, v. 382, n. 15, p. 1395–1407, 9 abr. 2020.
MORAN, A. E. et al. Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010. Circulation, v. 129, n. 14, p. 1483–1492, 8 abr. 2014.
PRADO-OLIVARES, J.; CHOVER-SIERRA, E. Preoperatory Anxiety in Patients Undergoing Cardiac Surgery. Diseases (Basel, Switzerland), v. 7, n. 2, p. E46, 19 jun. 2019.
VELAZQUEZ, E. J. et al. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. The New England journal of medicine, v. 364, n. 17, p. 1607–1616, 28 abr. 2011.
